Table 2: Lipid metabolism parameters and atherogenic indices in patients with type 2 DM with CAN (M±m).

Parameters

Patients with type 2 DM (n = 107)

 

Without CAN [group 1 (n = 16)]

Subclinical CAN [group 2 (n = 19)]

Definite CAN [group 3 (n = 72)]

Group 4 [control group (n = 14)]

TC, mmol/L

4.82±0.26

5.21±0.42

6.27±0.11§**††

4.28±0.22

LDL-C, mmol/L

2.99±0.25*

3.08±0.34

4.33±0.1§**††

2.37±0.15

HDL-C, mmol/L

1.06±0.07*

0.91±0.05

0.79±0.02§**††

1.26±0.06

TG, mmol/L

1.67±0.12*

2.65±0.35

2.56±0.11§§**††

1.26±0.15

AC

3.97±0.56*

5.34±0.82

7.24±0.26§**††

2.45±0.13

TG/HDL-C

1.77±0.24*

3.38±0.6

3.42±0.17§**

1.04±0.14

TyG index

8.89±0.08*

9.29±0.14

9.41±0.05§**

8.37±0.12

DM: Diabetes Mellitus; CAN: Cardiovascular Autonomic Neuropathy; TC: Total Cholesterol; LDL-C: Low-Density Lipoprotein Cholesterol; HDL-C: High-Density Lipoprotein Cholesterol; AC: Atherogenic Coefficient; TG: Triglyceride; TG/HDL-C: Triglyceride/High-Density Lipoprotein Cholesterol Ratio; TyG: Triglyceride-Glucose Index.